Our findings and those of others relating BMI and disease severity in adults [8], contrast with the increased risk of MS associated with higher BMI during adolescence noted in prior studies [5], [6], possibly through immunologic modulation by hormones such as leptin and adiponectin [29]–[32]. The gene discussed is ADIPOQ; the disease is myeloid sarcoma.